The results show that the non-imidazole H3R antagonist DL77 ameliorated cognitive deficits induced by the NMDA receptor antagonist MK801 in an inhibitory PAP and in NOR paradigms in rats (Figure 6). The gene discussed is HRH3; the disease is Cognitive impairment.